Information Library
Results for: Safety & Ethics
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Re-ignite Product Development and Sales with Data Insights: Fueling Innovation Fact Sheet
Brochure — November 17, 2011
What Will Drive Biopharma’s Future? The long-dreaded crisis is staring us all in the face: What will take the place of expiring blockbusters with few prospects in hand? Spending on R&D more than doubled after 2002, but the output doesn’t match the investment. The number of new molecular entities has remained a disappointment, averaging only around 20 per year in the US. The big question is how can drug developers carve out a strategic path to innovation? -
Quintiles Names Jeffrey Spaeder Chief Medical and Scientific Officer
Press Release — August 3, 2011 - Quintiles announced the appointment of Jeffrey A. Spaeder, M.D., as its Chief Medical and Scientific Officer, representing the company's position on a wide variety of governance, ethical and scientific issues.
-
Cardiovascular Safety Watch
Hear from the Experts — December 17, 2010
Dr. Rick Turner's inaugural cardiac safety column in Journal for Clinical Studies discusses the automation of ECG interval readings. -
Cardiovascular Safety Watch
Hear from the Experts — December 17, 2010
Can non-clinical investigations predict the degree of proarrhythmic liability in clinical trials? -
Cardiovascular Safety Watch
Hear from the Experts — December 17, 2010
Following advisory committees' recommendations concerning rosiglitazone, the FDA did not withdraw the drug but did require a risk evaluation and mitigation strategy. -
Japanese Cardiac Safety Requirements
White Paper — December 6, 2010
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) recently implemented ICH Guideline E14, an important regulatory concern for companies aiming to market their drugs in that country. -
Podcast: Cardiac Safety in Clinical Research
Hear from the Experts — September 24, 2010
J.Rick Turner, Ph.D., Senior Scientific Director, Cardiac Safety Services at Quintiles, discusses the importance of cardiovascular assessments in clinical development. -
New HIPAA Regulations and Their Impact on Clinical Research
Hear from the Experts — April 20, 2010
In this article in Update magazine from FDLI, Quintiles' Judy Beach explains recent HIPAA changes and the potential impact on clinical research. -
Podcast: New Realities Require New Approach
Hear from the Experts — December 1, 2009
Dr. Uwe Maennl, Vice President and Global Head of Lifecycle Safety, explains why taking a lifecycle approach to safety is a business imperative. -
Enhancing a Culture of Safety in the Life Sciences Sector
Hear from the Experts — October 6, 2009
Axel Olsen stresses that stakeholder collaboration is the key to improving drug safety.
